Joshua R. Disbrow
2020 - AYTU BIOPHARMA
In 2020, Joshua R. Disbrow earned a total compensation of $1.6M as Chief Executive Officer at AYTU BIOPHARMA, a 52% increase compared to previous year.
Compensation breakdown
| Bonus | $185,000 |
|---|---|
| Option Awards | $140,330 |
| Salary | $607,620 |
| Stock Awards | $652,500 |
| Total | $1,585,450 |
Disbrow received $652.5K in stock awards, accounting for 41% of the total pay in 2020.
Disbrow also received $185K in bonus, $140.3K in option awards and $607.6K in salary.
Rankings
In 2020, Joshua R. Disbrow's compensation ranked 6,595th out of 13,090 executives tracked by ExecPay. In other words, Disbrow earned more than 49.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 6,595 out of 13,090 | 50th |
Division Manufacturing | 2,734 out of 5,621 | 51st |
Major group Chemicals And Allied Products | 1,102 out of 2,254 | 51st |
Industry group Drugs | 956 out of 1,954 | 51st |
Industry Pharmaceutical Preparations | 715 out of 1,459 | 51st |
Source: SEC filing on April 16, 2021.
Disbrow's colleagues
We found two more compensation records of executives who worked with Joshua R. Disbrow at AYTU BIOPHARMA in 2020.
News
AYTU BIOPHARMA CEO Joshua Disbrow's 2023 pay rises 20% to $708K
May 10, 2024
AYTU BIOPHARMA CEO Joshua Disbrow's 2021 pay jumps 291% to $6.2M
April 7, 2022
AYTU BIOPHARMA CEO Joshua Disbrow's 2020 pay jumps 52% to $1.6M
April 16, 2021
AYTU BIOPHARMA CEO Joshua Disbrow's 2019 pay jumps 72% to $1M
March 5, 2020
AYTU BIOPHARMA CEO Joshua Disbrow's 2018 pay falls 42% to $606K
February 25, 2019